87 related articles for article (PubMed ID: 2729556)
1. Fluorescence-based viability assay for studies of reactive drug intermediates.
Leeder JS; Dosch HM; Harper PA; Lam P; Spielberg SP
Anal Biochem; 1989 Mar; 177(2):364-72. PubMed ID: 2729556
[TBL] [Abstract][Full Text] [Related]
2. Cellular toxicity of sulfamethoxazole reactive metabolites--I. Inhibition of intracellular esterase activity prior to cell death.
Leeder JS; Dosch HM; Spielberg SP
Biochem Pharmacol; 1991 Feb; 41(4):567-74. PubMed ID: 1997005
[TBL] [Abstract][Full Text] [Related]
3. Cellular toxicity of sulfamethoxazole reactive metabolites--II. Inhibition of natural killer activity in human peripheral blood mononuclear cells.
Leeder JS; Nakhooda A; Spielberg SP; Dosch HM
Biochem Pharmacol; 1991 Feb; 41(4):575-83. PubMed ID: 1997006
[TBL] [Abstract][Full Text] [Related]
4. Limitations of the fluorescent probe viability assay.
Massaro EJ; Elstein KH; Zucker RM; Bair KW
Mol Toxicol; 1989; 2(4):271-84. PubMed ID: 2490980
[TBL] [Abstract][Full Text] [Related]
5. In vitro formation, disposition and toxicity of N-acetoxy-sulfamethoxazole, a potential mediator of sulfamethoxazole toxicity.
Nakamura H; Uetrecht J; Cribb AE; Miller MA; Zahid N; Hill J; Josephy PD; Grant DM; Spielberg SP
J Pharmacol Exp Ther; 1995 Sep; 274(3):1099-104. PubMed ID: 7562475
[TBL] [Abstract][Full Text] [Related]
6. Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity.
Cribb AE; Miller M; Leeder JS; Hill J; Spielberg SP
Drug Metab Dispos; 1991; 19(5):900-6. PubMed ID: 1686233
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity of sulfonamide reactive metabolites: apoptosis and selective toxicity of CD8(+) cells by the hydroxylamine of sulfamethoxazole.
Hess DA; Sisson ME; Suria H; Wijsman J; Puvanesasingham R; Madrenas J; Rieder MJ
FASEB J; 1999 Oct; 13(13):1688-98. PubMed ID: 10506572
[TBL] [Abstract][Full Text] [Related]
8. A cytotoxicity assay utilizing a fluorescent dye that determines accurate surviving fractions of cells.
Sellers JR; Cook S; Goldmacher VS
J Immunol Methods; 1994 Jun; 172(2):255-64. PubMed ID: 8034974
[TBL] [Abstract][Full Text] [Related]
9. Novel non-labile covalent binding of sulfamethoxazole reactive metabolites to cultured human lymphoid cells.
Summan M; Cribb AE
Chem Biol Interact; 2002 Nov; 142(1-2):155-73. PubMed ID: 12399161
[TBL] [Abstract][Full Text] [Related]
10. An in vitro investigation of predisposition to sulphonamide idiosyncratic toxicity in dogs.
Cribb AE; Spielberg SP
Vet Res Commun; 1990; 14(3):241-52. PubMed ID: 2382408
[TBL] [Abstract][Full Text] [Related]
11. A novel in vitro screening assay for trypanocidal activity using the fluorescent dye BCECF-AM.
Obexer W; Schmid C; Brun R
Trop Med Parasitol; 1995 Mar; 46(1):45-8. PubMed ID: 7631128
[TBL] [Abstract][Full Text] [Related]
12. Time-course of toxicity of reactive sulfonamide metabolites.
Rieder MJ; Krause R; Bird IA
Toxicology; 1995 Jan; 95(1-3):141-6. PubMed ID: 7825180
[TBL] [Abstract][Full Text] [Related]
13. Is hydroxylamine-induced cytotoxicity a valid marker for hypersensitivity reactions to sulfamethoxazole in human immunodeficiency virus-infected individuals?
Reilly TP; MacArthur RD; Farrough MJ; Crane LR; Woster PM; Svensson CK
J Pharmacol Exp Ther; 1999 Dec; 291(3):1356-64. PubMed ID: 10565861
[TBL] [Abstract][Full Text] [Related]
14. Combined ascorbate and glutathione deficiency leads to decreased cytochrome b5 expression and impaired reduction of sulfamethoxazole hydroxylamine.
Bhusari S; Abouraya M; Padilla ML; Pinkerton ME; Drescher NJ; Sacco JC; Trepanier LA
Arch Toxicol; 2010 Aug; 84(8):597-607. PubMed ID: 20221587
[TBL] [Abstract][Full Text] [Related]
15. Interactions between N-acetyl-p-benzoquinone imine and fluorescent calcium probes: implications for mechanistic toxicology.
Riley RJ; Leeder JS; Dosch HM; Spielberg SP
Anal Biochem; 1990 Dec; 191(2):253-61. PubMed ID: 2085171
[TBL] [Abstract][Full Text] [Related]
16. The hydroxylamine of sulfamethoxazole synergizes with FK506 and cyclosporin A, inhibiting T-cell proliferation.
Hess DA; Bird IA; Almawi WY; Rieder MJ
J Pharmacol Exp Ther; 1997 Apr; 281(1):540-8. PubMed ID: 9103542
[TBL] [Abstract][Full Text] [Related]
17. Testing a dual-fluorescence assay to monitor the viability of filamentous cyanobacteria.
Johnson TJ; Hildreth MB; Gu L; Zhou R; Gibbons WR
J Microbiol Methods; 2015 Jun; 113():57-64. PubMed ID: 25889626
[TBL] [Abstract][Full Text] [Related]
18. Estimation of intramitochondrial pCa and pH by fura-2 and 2,7 biscarboxyethyl-5(6)-carboxyfluorescein (BCECF) fluorescence.
Davis MH; Altschuld RA; Jung DW; Brierley GP
Biochem Biophys Res Commun; 1987 Nov; 149(1):40-5. PubMed ID: 3689416
[TBL] [Abstract][Full Text] [Related]
19. Drug efflux transport properties of 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester (BCECF-AM) and its fluorescent free acid, BCECF.
Bachmeier CJ; Trickler WJ; Miller DW
J Pharm Sci; 2004 Apr; 93(4):932-42. PubMed ID: 14999730
[TBL] [Abstract][Full Text] [Related]
20. Effect of lipopolysaccharide (LPS)-evoked host defense activation on hepatic microsomal formation and reduction of sulfamethoxazole hydroxylamine in the rat.
Cribb AE; McQuaid T; Renton KW
Biochem Pharmacol; 2001 Aug; 62(4):457-9. PubMed ID: 11448455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
